Graves Orbitopathy

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease

Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Immunological Follow-up of Patients With Basedow's Orbitopathy